Salix Pharmaceuticals (SLXP) 152.35 $SLXP
Seeking Alpha's Biotech Weekly: Crush-Proof Pfizer, Achillion's HCV Crusher, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 13, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
VRX: 167.00 (-0.50), ACT: 285.37 (+3.71), MDT: 75.26 (+0.33), XON: 39.30 (+1.05), CTIC: 2.23 (-0.02), PFNX: 12.45 (+0.29), JNJ: 99.62 (+1.18), ANTM: 141.05 (-0.95), NVAX: 8.80 (+0.40), SHPG: 239.82 (+6.11), ABBV: 58.05 (+1.00), TBPH: 18.51 (+0.28), SNY: 49.42 (+0.82), ALQA: 6.14 (+0.09), REGN: 402.40 (+0.66), ONCY: 0.51 (+0.02), PFE: 34.64 (-0.23), SLXP: 152.35 (+3.17), EPRS: 7.67 (+0.67), AMGN: 153.48 (+0.30), NKTR: 13.54 (-0.14), ZTS: 45.46 (-0.33), GILD: 101.90 (+1.10), ACHN: 10.89 (-0.20), GERN: 3.03 (unch)
35.4% Return Seen to Date on SmarTrend Salix Pharmaceuticals Call (SLXP)
Comtex SmarTrend(R) - Fri Feb 13, 10:58AM CST
SmarTrend identified an Uptrend for Salix Pharmaceuticals (NASDAQ:SLXP) on December 17th, 2014 at $112.22. In approximately 2 months, Salix Pharmaceuticals has returned 35.43% as of today's recent price of $151.99.
SLXP: 152.35 (+3.17)
Today's Market: Earnings Moving These Stocks, M&A In Pharma And Big Management Shakeups
Matthew Smith - at Seeking Alpha - Fri Feb 13, 8:56AM CST
VRX: 167.00 (-0.50), CAG: 34.83 (-1.59), SHPG: 239.82 (+6.11), SLXP: 152.35 (+3.17), NPSP: 45.88 (+0.03), KRFT: 64.42 (-1.75), AIG: 53.96 (+1.51), ZNGA: 2.24 (-0.42), KING: 16.70 (+1.96)
Technical Notes Covering Pharma Equities -- Valeant Pharma Intl., Salix Pharma, Medicines, Hospira, and Horizon Pharma
PR Newswire - Fri Feb 13, 7:45AM CST
Editor Note: For more information about this release, please scroll to bottom.
VRX: 167.00 (-0.50), MDCO: 29.79 (+0.91), HZNP: 16.84 (-0.41), SLXP: 152.35 (+3.17), HSP: 87.35 (unch), VRX.TO: 207.95 (-1.47)
Salix Pharmaceuticals (SLXP) Stock Higher Today on Shire Takeover Talk
at The Street - Fri Feb 13, 7:21AM CST
Salix Pharmaceuticals (SLXP) is reportedly a takeover target of Shire (SHPG) which is said to be working on a potential offer.
SLXP: 152.35 (+3.17)
Wall Street Breakfast: GDP Figures Lead Europe Higher
Wall Street Breakfast - at Seeking Alpha - Fri Feb 13, 5:31AM CST
VRX: 167.00 (-0.50), SPY: 209.78 (+0.86), QQQ: 106.91 (+0.91), SHPG: 239.82 (+6.11), SLXP: 152.35 (+3.17), GM: 37.62 (-0.40), AIG: 53.96 (+1.51), ZNGA: 2.24 (-0.42), GRPN: 7.97 (+0.51), FSL: 37.53 (+2.83), MT: 11.20 (+0.74)
Shire now on the hunt for Salix
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 12:58AM CST
VRX: 167.00 (-0.50), SHPG: 239.82 (+6.11), SLXP: 152.35 (+3.17)
After Yesterday's Rally of 4.07% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Feb 12, 3:53PM CST
Salix Pharmaceuticals (NASDAQ:SLXP) traded in a range yesterday that spanned from a low of $142.90 to a high of $152.00. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $144.00 on volume of 3.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SLXP: 152.35 (+3.17)
Valeant close to a bid for Salix
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 2:53PM CST
VRX: 167.00 (-0.50), SLXP: 152.35 (+3.17)
Volume Rises As Stocks Trade Near Session High
at Investor's Business Daily - Thu Feb 12, 2:24PM CST
Stocks were trading near the day's high going into the last hour of the session Thursday, with the Nasdaq at its highest level since March 2000, the month that the dot-com bubble burst. The Nasdaq rose 1%, the S&P 500 gained 0.9% and the Dow Jones...
HAR: 136.40 (-3.18), BIDU: 212.13 (+7.11), AAP: 150.16 (-1.26), SLXP: 152.35 (+3.17), AAPL: 127.08 (+0.62), CSCO: 29.43 (-0.03)
Shire Moves Up On NPS Potential; Q4 Earnings Miss
at Investor's Business Daily - Thu Feb 12, 9:45AM CST
Shares of Shire (SHPG) moved higher early Thursday as the Irish drugmaker's better-than-expected quarterly revenue and upbeat 2015 outlook offset an earnings miss. Reporting before the open, Shire logged fourth-quarter earnings of $2.63 per American...
AGN: 229.49 (+1.87), VRX: 167.00 (-0.50), SHPG: 239.82 (+6.11), SLXP: 152.35 (+3.17), NPSP: 45.88 (+0.03), ABBV: 58.05 (+1.00)
Congratulations Covidien: You Escaped In Time
Chris DeMuth Jr. - Seeking Alpha - Wed Feb 11, 8:19AM CST
Originally published on February 4, 2015 The Shakedown In 2014, Obama vowed to punish tax inverting companies by any means necessary - inside and outside of legislation. He took scalps including Shire (NASDAQ: SHPG ) and Walgreens (NASDAQ: WBA...
VRX: 167.00 (-0.50), WBA: 78.73 (-1.23), MDT: 75.26 (+0.33), COV: 106.71 (-1.36), SHPG: 239.82 (+6.11), SLXP: 152.35 (+3.17), NPSP: 45.88 (+0.03), ABBV: 58.05 (+1.00)
6 Big Pharmaceutical Companies You Don't Want In Your Portfolio
at The Street - Tue Feb 10, 7:17AM CST
Which big pharmaceutical stocks should investors stay away from in 2015?
MNK: 115.01 (+2.51), ENDP: 84.01 (+1.12), JAZZ: 169.69 (+6.89), AZN: 69.96 (+0.20), SLXP: 152.35 (+3.17), GSK: 47.94 (+1.99)
Salix Pharmaceuticals Up 25.2% Since SmarTrend Uptrend Call (SLXP)
Comtex SmarTrend(R) - Fri Feb 06, 9:36AM CST
SmarTrend identified an Uptrend for Salix Pharmaceuticals (NASDAQ:SLXP) on December 17th, 2014 at $112.23. In approximately 2 months, Salix Pharmaceuticals has returned 25.25% as of today's recent price of $140.56.
SLXP: 152.35 (+3.17)
Salix Pharmaceuticals (SLXP) in Focus: Stock Jumps 5.1% - Tale of the Tape
Zacks Research Stuff - Zacks Investment Research - Wed Feb 04, 8:21AM CST
Salix Pharmaceuticals Ltd. (SLXP) was a big mover last session, as the company saw its shares rise over 5% on the day.
SLXP: 152.35 (+3.17), BIOD: 1.38 (-0.14)
Salix promotes Dr William P. Forbes to president of Medical, Research and Development and CDO
M2 - Tue Feb 03, 8:25PM CST
Pharmaceutical company Salix Pharmaceuticals (NasdaqGS:SLXP) said on Monday that Dr William P. Forbes, PharmD has been promoted to the position of president, Medical, Research and Development and chief development officer.
SLXP: 152.35 (+3.17)
Salix Pharmaceuticals Set to Possibly Pullback After Yesterday's Rally of 5.10%
Comtex SmarTrend(R) - Tue Feb 03, 4:08PM CST
Salix Pharmaceuticals (NASDAQ:SLXP) traded in a range yesterday that spanned from a low of $130.65 to a high of $144.91. Yesterday, the shares gained 5.1%, which took the trading range above the 3-day high of $137.61 on volume of 5.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SLXP: 152.35 (+3.17)
Stocks On Pace For Second Straight Gain; Salix Rallies
at Investor's Business Daily - Tue Feb 03, 1:59PM CST
Stocks strengthened late Tuesday and were poised for a second straight gain. The Dow Jones industrial average jumped 1.3%, led by Caterpillar (CAT), Chevron (CVX) and Exxon Mobil (XOM). The S&P 500 climbed 1% and the Nasdaq was up 0.5%. Volume was...
VRX: 167.00 (-0.50), SLXP: 152.35 (+3.17), EW: 134.23 (+1.89), XOM: 93.37 (+1.00), DIS: 104.17 (+0.59), GILD: 101.90 (+1.10), CMG: 674.89 (+4.60), CAT: 85.13 (+1.60), CVX: 112.78 (+1.92), PAYC: 32.37 (-0.71)
Salix jumps on yet another buyout rumor
Seeking Alpha - at Seeking Alpha - Tue Feb 03, 11:43AM CST
VRX: 167.00 (-0.50), SLXP: 152.35 (+3.17)
Watch Out: Barbarians At The Gate For Salix Pharmaceuticals (SLXP)
at The Street - Tue Feb 03, 11:27AM CST
Trade-Ideas LLC identified Salix Pharmaceuticals (SLXP) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
SLXP: 152.35 (+3.17)
Seeking Alpha's Biotech Weekly: Crush-Proof Pfizer, Achillion's HCV Crusher, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 13, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
VRX: 167.00 (-0.50), ACT: 285.37 (+3.71), MDT: 75.26 (+0.33), XON: 39.30 (+1.05), CTIC: 2.23 (-0.02), PFNX: 12.45 (+0.29), JNJ: 99.62 (+1.18), ANTM: 141.05 (-0.95), NVAX: 8.80 (+0.40), SHPG: 239.82 (+6.11), ABBV: 58.05 (+1.00), TBPH: 18.51 (+0.28), SNY: 49.42 (+0.82), ALQA: 6.14 (+0.09), REGN: 402.40 (+0.66), ONCY: 0.51 (+0.02), PFE: 34.64 (-0.23), SLXP: 152.35 (+3.17), EPRS: 7.67 (+0.67), AMGN: 153.48 (+0.30), NKTR: 13.54 (-0.14), ZTS: 45.46 (-0.33), GILD: 101.90 (+1.10), ACHN: 10.89 (-0.20), GERN: 3.03 (unch)
35.4% Return Seen to Date on SmarTrend Salix Pharmaceuticals Call (SLXP)
Comtex SmarTrend(R) - Fri Feb 13, 10:58AM CST
SmarTrend identified an Uptrend for Salix Pharmaceuticals (NASDAQ:SLXP) on December 17th, 2014 at $112.22. In approximately 2 months, Salix Pharmaceuticals has returned 35.43% as of today's recent price of $151.99.
SLXP: 152.35 (+3.17)
Today's Market: Earnings Moving These Stocks, M&A In Pharma And Big Management Shakeups
Matthew Smith - at Seeking Alpha - Fri Feb 13, 8:56AM CST
VRX: 167.00 (-0.50), CAG: 34.83 (-1.59), SHPG: 239.82 (+6.11), SLXP: 152.35 (+3.17), NPSP: 45.88 (+0.03), KRFT: 64.42 (-1.75), AIG: 53.96 (+1.51), ZNGA: 2.24 (-0.42), KING: 16.70 (+1.96)
Technical Notes Covering Pharma Equities -- Valeant Pharma Intl., Salix Pharma, Medicines, Hospira, and Horizon Pharma
PR Newswire - Fri Feb 13, 7:45AM CST
Editor Note: For more information about this release, please scroll to bottom.
VRX: 167.00 (-0.50), MDCO: 29.79 (+0.91), HZNP: 16.84 (-0.41), SLXP: 152.35 (+3.17), HSP: 87.35 (unch), VRX.TO: 207.95 (-1.47)
Salix Pharmaceuticals (SLXP) Stock Higher Today on Shire Takeover Talk
at The Street - Fri Feb 13, 7:21AM CST
Salix Pharmaceuticals (SLXP) is reportedly a takeover target of Shire (SHPG) which is said to be working on a potential offer.
SLXP: 152.35 (+3.17)
Wall Street Breakfast: GDP Figures Lead Europe Higher
Wall Street Breakfast - at Seeking Alpha - Fri Feb 13, 5:31AM CST
VRX: 167.00 (-0.50), SPY: 209.78 (+0.86), QQQ: 106.91 (+0.91), SHPG: 239.82 (+6.11), SLXP: 152.35 (+3.17), GM: 37.62 (-0.40), AIG: 53.96 (+1.51), ZNGA: 2.24 (-0.42), GRPN: 7.97 (+0.51), FSL: 37.53 (+2.83), MT: 11.20 (+0.74)
Shire now on the hunt for Salix
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 12:58AM CST
VRX: 167.00 (-0.50), SHPG: 239.82 (+6.11), SLXP: 152.35 (+3.17)
After Yesterday's Rally of 4.07% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Feb 12, 3:53PM CST
Salix Pharmaceuticals (NASDAQ:SLXP) traded in a range yesterday that spanned from a low of $142.90 to a high of $152.00. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $144.00 on volume of 3.9 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SLXP: 152.35 (+3.17)
Valeant close to a bid for Salix
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 2:53PM CST
VRX: 167.00 (-0.50), SLXP: 152.35 (+3.17)
Volume Rises As Stocks Trade Near Session High
at Investor's Business Daily - Thu Feb 12, 2:24PM CST
Stocks were trading near the day's high going into the last hour of the session Thursday, with the Nasdaq at its highest level since March 2000, the month that the dot-com bubble burst. The Nasdaq rose 1%, the S&P 500 gained 0.9% and the Dow Jones...
HAR: 136.40 (-3.18), BIDU: 212.13 (+7.11), AAP: 150.16 (-1.26), SLXP: 152.35 (+3.17), AAPL: 127.08 (+0.62), CSCO: 29.43 (-0.03)
Shire Moves Up On NPS Potential; Q4 Earnings Miss
at Investor's Business Daily - Thu Feb 12, 9:45AM CST
Shares of Shire (SHPG) moved higher early Thursday as the Irish drugmaker's better-than-expected quarterly revenue and upbeat 2015 outlook offset an earnings miss. Reporting before the open, Shire logged fourth-quarter earnings of $2.63 per American...
AGN: 229.49 (+1.87), VRX: 167.00 (-0.50), SHPG: 239.82 (+6.11), SLXP: 152.35 (+3.17), NPSP: 45.88 (+0.03), ABBV: 58.05 (+1.00)
Congratulations Covidien: You Escaped In Time
Chris DeMuth Jr. - Seeking Alpha - Wed Feb 11, 8:19AM CST
Originally published on February 4, 2015 The Shakedown In 2014, Obama vowed to punish tax inverting companies by any means necessary - inside and outside of legislation. He took scalps including Shire (NASDAQ: SHPG ) and Walgreens (NASDAQ: WBA...
VRX: 167.00 (-0.50), WBA: 78.73 (-1.23), MDT: 75.26 (+0.33), COV: 106.71 (-1.36), SHPG: 239.82 (+6.11), SLXP: 152.35 (+3.17), NPSP: 45.88 (+0.03), ABBV: 58.05 (+1.00)
6 Big Pharmaceutical Companies You Don't Want In Your Portfolio
at The Street - Tue Feb 10, 7:17AM CST
Which big pharmaceutical stocks should investors stay away from in 2015?
MNK: 115.01 (+2.51), ENDP: 84.01 (+1.12), JAZZ: 169.69 (+6.89), AZN: 69.96 (+0.20), SLXP: 152.35 (+3.17), GSK: 47.94 (+1.99)
Salix Pharmaceuticals Up 25.2% Since SmarTrend Uptrend Call (SLXP)
Comtex SmarTrend(R) - Fri Feb 06, 9:36AM CST
SmarTrend identified an Uptrend for Salix Pharmaceuticals (NASDAQ:SLXP) on December 17th, 2014 at $112.23. In approximately 2 months, Salix Pharmaceuticals has returned 25.25% as of today's recent price of $140.56.
SLXP: 152.35 (+3.17)
Salix Pharmaceuticals (SLXP) in Focus: Stock Jumps 5.1% - Tale of the Tape
Zacks Research Stuff - Zacks Investment Research - Wed Feb 04, 8:21AM CST
Salix Pharmaceuticals Ltd. (SLXP) was a big mover last session, as the company saw its shares rise over 5% on the day.
SLXP: 152.35 (+3.17), BIOD: 1.38 (-0.14)
Salix promotes Dr William P. Forbes to president of Medical, Research and Development and CDO
M2 - Tue Feb 03, 8:25PM CST
Pharmaceutical company Salix Pharmaceuticals (NasdaqGS:SLXP) said on Monday that Dr William P. Forbes, PharmD has been promoted to the position of president, Medical, Research and Development and chief development officer.
SLXP: 152.35 (+3.17)
Salix Pharmaceuticals Set to Possibly Pullback After Yesterday's Rally of 5.10%
Comtex SmarTrend(R) - Tue Feb 03, 4:08PM CST
Salix Pharmaceuticals (NASDAQ:SLXP) traded in a range yesterday that spanned from a low of $130.65 to a high of $144.91. Yesterday, the shares gained 5.1%, which took the trading range above the 3-day high of $137.61 on volume of 5.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SLXP: 152.35 (+3.17)
Stocks On Pace For Second Straight Gain; Salix Rallies
at Investor's Business Daily - Tue Feb 03, 1:59PM CST
Stocks strengthened late Tuesday and were poised for a second straight gain. The Dow Jones industrial average jumped 1.3%, led by Caterpillar (CAT), Chevron (CVX) and Exxon Mobil (XOM). The S&P 500 climbed 1% and the Nasdaq was up 0.5%. Volume was...
VRX: 167.00 (-0.50), SLXP: 152.35 (+3.17), EW: 134.23 (+1.89), XOM: 93.37 (+1.00), DIS: 104.17 (+0.59), GILD: 101.90 (+1.10), CMG: 674.89 (+4.60), CAT: 85.13 (+1.60), CVX: 112.78 (+1.92), PAYC: 32.37 (-0.71)
Salix jumps on yet another buyout rumor
Seeking Alpha - at Seeking Alpha - Tue Feb 03, 11:43AM CST
VRX: 167.00 (-0.50), SLXP: 152.35 (+3.17)
Watch Out: Barbarians At The Gate For Salix Pharmaceuticals (SLXP)
at The Street - Tue Feb 03, 11:27AM CST
Trade-Ideas LLC identified Salix Pharmaceuticals (SLXP) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
SLXP: 152.35 (+3.17)
